Jazz Pharmaceuticals Ownership | Who Owns Jazz Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Jazz Pharmaceuticals Ownership Summary


Jazz Pharmaceuticals is owned by 104.62% institutional investors, 2.99% insiders. Blackrock is the largest institutional shareholder, holding 9.83% of JAZZ shares. Pacer US Cash Cows 100 ETF is the top mutual fund, with 3.55% of its assets in Jazz Pharmaceuticals shares.

JAZZ Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockJazz Pharmaceuticals104.62%2.99%-7.60%
SectorHealthcare Stocks 50.47%12.28%37.25%
IndustryBiotech Stocks 49.08%12.05%38.87%
IdeaCannabis Stocks List20.62%11.72%67.65%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock6.15M9.83%$655.94M
Vanguard group5.92M9.75%$1.01B
Blackrock funding, inc. /de5.97M9.64%$1.44B
Fmr4.61M7.45%$1.11B
Vanguard capital management2.73M4.41%$657.76M
Capital world investors2.70M4.36%$650.04M
Lsv asset management2.28M3.68%$548.24M
Franklin resources2.04M3.30%$491.64M
State street2.00M3.23%$481.90M
Dimensional fund advisors lp1.71M2.77%$412.91M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Krensavage asset management167.82K15.36%$40.44M
Polaris capital management328.97K7.47%$79.27M
Tri locum partners lp221.72K6.57%$53.43M
Gmt capital453.50K5.69%$109.28M
Saturn v capital management160.94K5.56%$38.78M
Superstring capital management lp40.89K5.31%$5.39M
Sofinnova investments365.34K4.55%$88.04M
Goldentree asset management lp294.44K4.12%$70.84M
Pfm health sciences, lp160.77K3.32%$38.74M
Fairbanks capital management21.99K3.14%$5.30M

Top Buyers

HolderShares% AssetsChange
Fmr4.61M0.05%2.33M
Norges bank656.84K0.02%656.84K
Mariner608.62K0.15%568.60K
Sixth street partners management company462.51K0.01%462.51K
Victory capital management686.72K0.09%430.12K

Top Sellers

HolderShares% AssetsChange
Ecor1 capital---1.71M
Baupost group llc/ma---1.27M
Camber capital management lp---1.15M
Blackrock6.15M0.01%-924.16K
Rubric capital management lp---616.62K

New Positions

HolderShares% AssetsChangeValue
Norges bank656.84K0.02%656.84K$158.28M
Sixth street partners management company462.51K0.01%462.51K$111.45M
Argent capital management200.07K1.52%200.07K$48.21M
Centre asset management75.80K2.14%75.80K$9.34M
Longaeva partners68.79K0.36%68.79K$16.58M

Sold Out

HolderChange
Whittier trust co of nevada-1.00
Private wealth asset management-1.00
Center for financial planning-1.00
Psi advisors-1.00
Kiker wealth management-1.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202665110.34%64,757,600-0.42%1040.95%37417.24%18712.65%
Mar 31, 2026398-32.88%35,288,267-42.71%570.56%210-32.26%112-42.27%
Dec 31, 2025394-23.79%42,392,171-30.10%690.71%191-15.49%134-31.98%
Sep 30, 2025488-2.59%58,731,791-0.37%951.03%208-15.10%1876.86%
Jun 30, 2025498-10.75%61,731,8556.44%1001.12%243-23.10%17512.18%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Pacer US Cash Cows 100 ETF2.16M3.55%3.19K
Capital Group Fundamental Invtrs Comp2.10M3.34%-
American Funds Fundamental Invs A2.10M3.34%-
iShares Core S&P Mid-Cap ETF2.16M3.32%66.00
Vanguard US Total Market Shares ETF1.84M3.03%-44.10K
Vanguard Morn Total Stk Mkt Idx Investor1.89M3.01%31.18K
Vanguard Total Stock Mkt Idx Inv1.89M3.01%31.18K
FullerThaler Behavioral Sm-Cp Eq R61.61M2.56%6.50K
FullerThaler Behavioral Small-Cap Equity1.56M2.41%-39.60K
FullerThaler Beh Small-Cap Equity SMA1.56M2.41%-39.60K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 03, 2026COZADD BRUCE C-Sell$1.52M
Jul 01, 2026COZADD BRUCE C-Sell$1.44M
Jun 15, 2026Smith Mark Douglas-Sell$266.75K
Jun 10, 2026Patil Neena M EVP & Chief Legal OfficerSell$278.20K
May 28, 2026Patil Neena M EVP & Chief Legal OfficerSell$282.47K

Insider Transactions Trends


DateBuySell
2026 Q3-2
2026 Q2-10
2026 Q1-19
2025 Q4-18
2025 Q3-5

JAZZ Ownership FAQ


Who Owns Jazz Pharmaceuticals?

Jazz Pharmaceuticals shareholders are primarily institutional investors at 104.62%, followed by 2.99% insiders and -7.61% retail investors. The average institutional ownership in Jazz Pharmaceuticals's industry, Biotech Stocks , is 49.08%, which Jazz Pharmaceuticals exceeds.

Who owns the most shares of Jazz Pharmaceuticals?

Jazz Pharmaceuticals’s largest shareholders are Blackrock (6.15M shares, 9.83%), Vanguard group (5.92M shares, 9.75%), and Blackrock funding, inc. /de (5.97M shares, 9.64%). Together, they hold 29.22% of Jazz Pharmaceuticals’s total shares outstanding.

Does Blackrock own Jazz Pharmaceuticals?

Yes, BlackRock owns 9.83% of Jazz Pharmaceuticals, totaling 6.15M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 655.94M$. In the last quarter, BlackRock decreased its holdings by -924K shares, a -13.07% change.

Who is Jazz Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Krensavage asset management is Jazz Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 15.36% of its assets in 167.82K Jazz Pharmaceuticals shares, valued at 40.44M$.

Who is the top mutual fund holder of Jazz Pharmaceuticals shares?

Pacer US Cash Cows 100 ETF is the top mutual fund holder of Jazz Pharmaceuticals shares, with 3.55% of its total shares outstanding invested in 2.16M Jazz Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools